Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Plasmodium falciparum heme detoxification system is a critical survival mechanism located within the parasite's acidic digestive vacuole (Jolt et al., 2008). During the intraerythrocytic stage, the parasite ingests and degrades host hemoglobin to obtain essential amino acids, a process that releases large quantities of free heme (ferriprotoporphyrin IX). Because free heme is highly toxic, causing oxidative stress and membrane damage, the parasite utilizes a specialized machinery—including the Heme Detoxification Protein (HDP) and Histidine-Rich Proteins (HRP2/3)—to sequester and crystallize heme into insoluble, non-toxic hemozoin (Sullivan et al., 1996). This detoxification pathway is the primary target for several classes of antimalarial drugs, most notably the quinolines like chloroquine, which bind to heme and prevent its incorporation into hemozoin crystals (Combrinck et al., 2013). The resulting accumulation of free heme leads to parasite death through oxidative damage. The emergence of resistance, mediated by mutations in transporters like the P. falciparum chloroquine resistance transporter (PfCRT), remains a significant challenge in targeting this system (Fidock et al., 2000). Monitoring this target often involves detecting PfHRP2, which serves as a key diagnostic biomarker for P. falciparum infection.
Inhibition of the biocrystallization of toxic free heme into inert hemozoin crystals within the parasite's digestive vacuole (Sullivan et al., 1996; Combrinck et al., 2013).
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Plasmodium falciparum heme detoxification system (PfHDS).